Rouen Study on Anxiety

Allergy testing is necessary to confirm a diagnosis of allergy, whether food, respiratory, drug, or hymenoptera venom. Although the vast majority of these tests are well tolerated, performing them carries a very low risk of inducing an allergic reaction in the patient, warranting continuous medical monitoring regardless of the allergy being investigated. A severe reaction can be observed, largely during oral or intravenous reintroduction tests, in up to 15% of series for food allergies, and even less for drug allergies. The perceived risk can vary between patients, and this subjective perception can be influenced by several factors, including personal experience, medical history, or access to information regarding allergy testing. Anxiety related to allergy testing can influence patient experience, but also test results.

NCT Number	NCT07034313
Lead Sponsor	University Hospital, Rouen
Conditions	Anxiety Disorder
Enrollment	300 participants
Start Date	2025-03-17
Primary Completion	2025-05-14 (estimated)
Study Completion	2025-11-01 (estimated)
Updated on ClinicalTrials.gov	2026-04-06